[1]
“Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma”, Radiol Oncol, vol. 49, no. 3, Oct. 2015, Accessed: Sep. 24, 2026. Available: https://radioloncol.com/index.php/ro/article/view/2368